News Articles for Brendan de Kauwe

A Perth executive has sued a Brisbane-registered company and several people related to it, including former federal minister Ken Wyatt, over a Bitcoin dispute.

Today's board moves wrap includes Kerry Gleeson, Bryn Hardcastle, Brendan de Kauwe, David Iverach, Guido Belgiorno-Nettis, and Chris Cook.

Stephen Buckley has been appointed company secretary of Intiger Group following the resignation of Sonu Cheema.

Legal proceedings started by two eSense-Lab directors, including Otsana Capital director Brendan de Kauwe, against the life sciences company in Israel have been dismissed.

Ramon Soares has resigned as chief financial officer and company secretary of Activistic due to other commitments.

A group of shareholders in life sciences company eSense-Lab has requisitioned a general meeting to remove three directors, including chief executive Haim Cohen, while also seeking to appoint MMJ Phytotech managing director Andreas Gedeon and Otsana Capital founder Faldi Ismail to the board.

Dormant Perth-based biotech company Pharmanet Group will re-emerge as a gold explorer after entering into an agreement to acquire Keras Australia by way of a reverse takeover.

Life sciences company eSense-Lab has enjoyed steady gains on its first day of trading on the ASX, after raising $3.5 million from investors in an initial public offering.

Local software and technology development company Investia Technologies is seeking an ASX listing through a reverse takeover of Advanced Engine Components.

Virax Holdings has agreed to acquire Pathway Oncology in a reverse takeover which will see the Australia-listed company gain control of a global licence for emerging anti-cancer technology.